Skip to content

HDfarma: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HDfarma

BE 0833.166.058
NACE 47.730, Retail sale of pharmaceutical products
financial year 2026 compared with 2025filed annual accounts (NBB)
Net result for the year
€121,927
2025 · €32,619+€89,308
Equity
€435,240
2025 · €313,313+€121,927
Cash
€428,144
2025 · €197,000+€231,143
Balance sheet total
€779,162
2025 · €654,099+€125,063

Largest movements

2025 to 2026
Assets
  • Cash +€231,143

    up €231,143 (+117%), from €197,000 to €428,144

    mainly Net result for the year (+€121,927) and Investment in fixed assets (net) (+€66,451)

  • Tangible fixed assets -€90,186

    down €90,186 (-27.9%), from €323,490 to €233,305

    of which Land and buildings: -€97,725

  • Stocks and contracts -€14,325

    down €14,325 (-14.6%), from €98,096 to €83,772

Equity and liabilities
  • Reserves +€121,927

    up €121,927 (+41.4%), from €294,713 to €416,640

    of which Distributable reserves: +€121,927

  • Tax, wage and social debts +€33,162

    up €33,162 (+168%), from €19,710 to €52,872

    of which Taxes: +€39,450

  • Debts after one year -€23,400

    down €23,400 (-8.9%), from €263,400 to €240,000

  • Current portion of long-term debt -€21,600

    no longer reported in 2026 (was €21,600)

  • Trade debts +€14,404

    up €14,404 (+62.6%), from €22,997 to €37,402

Income statement
  • Gross operating margin +€131,467

    up €131,467 (+118%), from €111,055 to €242,522

  • Taxes +€47,552

    up €47,552 (+406%), from €11,703 to €59,255

  • Depreciation -€10,841

    down €10,841 (-31.4%), from €34,576 to €23,734

  • Staff costs +€8,817

    up €8,817 (+103%), from €8,526 to €17,343

  • Financial charges -€2,598

    down €2,598 (-12.7%), from €20,470 to €17,872

From the 2025 result to the 2026 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2025 €32,619
Gross operating margin +€131,467
Staff costs -€8,817
Depreciation +€10,841
Other operating charges +€471
Financial income +€299
Financial charges +€2,598
Taxes -€47,552
Result 2026 €121,927
raises the resultlowers the result

Derived cash bridge

cash 2025 to 2026

Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€209,692
Investment +€66,451
Financing -€45,000
Cash 2025 €197,000
Net result for the year +€121,927
Depreciation +€23,734
Stocks and contracts +€14,325
Receivables within one year -€1,484
Deferred charges and accrued income +€3,054
Trade debts +€14,404
Tax, wage and social debts +€33,162
Accrued charges and deferred income +€569
Investment in fixed assets (net) +€66,451
Debts after one year -€23,400
Current portion of long-term debt -€21,600
Cash 2026 €428,144
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2025 2026 Change %
Total assets 20/58 €654,099 €779,162 +€125,063 +19.1%
Fixed assets 21/28 €323,490 €233,305 -€90,186 -27.9%
Tangible fixed assets 22/27 €323,490 €233,305 -€90,186 -27.9%
Land and buildings 22 €319,594 €221,868 -€97,725 -30.6%
Plant, machinery and equipment 23 - €4,296 +€4,296
Furniture and vehicles 24 €3,896 €7,140 +€3,243 +83.2%
Current assets 29/58 €330,609 €545,857 +€215,248 +65.1%
Stocks and contracts in progress 3 €98,096 €83,772 -€14,325 -14.6%
Stocks 30/36 €98,096 €83,772 -€14,325 -14.6%
Amounts receivable within one year 40/41 €32,458 €33,942 +€1,484 +4.6%
Trade receivables 40 €29,162 €32,800 +€3,638 +12.5%
Other amounts receivable 41 €3,297 €1,142 -€2,154 -65.4%
Cash at bank and in hand 54/58 €197,000 €428,144 +€231,143 +117%
Deferred charges and accrued income 490/1 €3,054 - -€3,054
Total equity and liabilities 10/49 €654,099 €779,162 +€125,063 +19.1%
Equity 10/15 €313,313 €435,240 +€121,927 +38.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €294,713 €416,640 +€121,927 +41.4%
Tax-exempt reserves 132 €18,750 €18,750 = 0.0%
Distributable reserves 133 €275,963 €397,890 +€121,927 +44.2%
Amounts payable 17/49 €340,786 €343,922 +€3,136 +0.9%
Amounts payable after more than one year 17 €263,400 €240,000 -€23,400 -8.9%
Financial debts 170/4 €263,400 €240,000 -€23,400 -8.9%
Amounts payable within one year 42/48 €64,307 €90,274 +€25,966 +40.4%
Current portion of amounts payable after more than one year 42 €21,600 - -€21,600
Trade debts 44 €22,997 €37,402 +€14,404 +62.6%
Suppliers 440/4 €22,997 €37,402 +€14,404 +62.6%
Taxes, remuneration and social security 45 €19,710 €52,872 +€33,162 +168%
Taxes 450/3 €9,709 €49,158 +€39,450 +406%
Remuneration and social security 454/9 €10,001 €3,713 -€6,288 -62.9%
Accrued charges and deferred income 492/3 €13,079 €13,648 +€569 +4.4%
Non-recurring operating income 76A - €169,065 +€169,065
Remuneration, social security and pensions 62 €8,526 €17,343 +€8,817 +103%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €34,576 €23,734 -€10,841 -31.4%
Other operating charges 640/8 €3,160 €2,689 -€471 -14.9%
Gross operating margin 9900 €111,055 €242,522 +€131,467 +118%
Operating profit (loss) 9901 €64,793 €198,756 +€133,962 +207%
Financial income 75/76B - €299 +€299
Recurring financial income 75 - €299 +€299
Financial charges 65/66B €20,470 €17,872 -€2,598 -12.7%
Recurring financial charges 65 €20,470 €17,872 -€2,598 -12.7%
Profit (loss) for the period before taxes 9903 €44,323 €181,182 +€136,859 +309%
Income taxes 67/77 €11,703 €59,255 +€47,552 +406%
Profit (loss) for the period 9904 €32,619 €121,927 +€89,308 +274%
Profit (loss) for the period to be appropriated 9905 €32,619 €121,927 +€89,308 +274%

Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.